Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Tropical Medicine and Hygiene

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4269/AJTMH.2004.71.758PMID 15642967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between age, molecular markers, and response to sulphadoxine–pyrimethamine treatment in Kampala, Uganda

  2004cited by this paper
• DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.

  2003cited by this paper
• Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.

  2003cited by this paper
• Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.

  2003cited by this paper
• Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.

  2003cited by this paper
• Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.

  2003cited by this paper
• Antifolate antimalarial resistance in southeast Africa: a population-based analysis.

  2003influential reference
• The evolution of drug-resistant malaria: the role of drug elimination half-life.

  2002cited by this paper
• Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.

  2002cited by this paper
• Increasing antimalarial drug resistance in Uganda and revision of the national drug policy

  2002cited by this paper
• Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

  2002cited by this paper
• Severe and complicated malaria.

  2002cited by this paper
• Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.

  2001cited by this paper
• The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.

  2001cited by this paper
• Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

  2001influential reference
• Folate Antagonists and Mechanisms of Resistance

  2001influential reference
• Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.

  2000cited by this paper
• Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda.

  2000cited by this paper
• Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

  2000cited by this paper
• Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites

  2000cited by this paper
• Lack of an association between the ASN-108 mutation in the dihydrofolate reductase gene and in vivo resistance to sulfadoxine/pyrimethamine in Plasmodium falciparum.

  1999cited by this paper
• Averting a malaria disaster.

  1999cited by this paper
• Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.

  1998cited by this paper
• A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance

  1997cited by this paper
• Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

  1997cited by this paper
• Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.

  1997cited by this paper
• Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.

  1995cited by this paper
• Severe and complicated malaria. Second edition. World Health Organization Division of Control of Tropical Diseases.

  1990cited by this paper
• Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases.

  1990cited by this paper
• Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.

  1988cited by this paper

• Meta-analysis on Plasmodium falciparum sulfadoxine-pyrimethamine resistance-conferring mutations in India identifies hot spots for genetic surveillance

  2023cites this paper
• Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.

  2022cites this paper
• Decreased susceptibility to dihydrofolate reductase inhibitors associated with genetic polymorphisms in Ugandan Plasmodium falciparum isolates.

  2021cites this paper
• Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance–Mediating Polymorphisms in Uganda

  2017cites this paper
• Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network

  2015cites this paper
• Prevalence of Plasmodium falciparum Resistance Markers to Sulfadoxine-Pyrimethamine among Pregnant Women Receiving Intermittent Preventive Treatment for Malaria in Uganda

  2015cites this paper
• Spatial and temporal analyses of sulphadoxine pyrimethamine resistance in African Plasmodium falciparum malaria

  2015cites this paper
• Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia

  2014cites this paper
• Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.

  2014cites this paper
• Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso

  2014cites this paper
• Selection of drug resistance-mediating Plasmodium

  2014cites this paper
• Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review

  2013cites this paper
• Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.

  2013cites this paper
• Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics

  2013cites this paper
• Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo

  2013cites this paper
• Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach

  2012cites this paper
• Peer Reviewed Title: Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola

  2011cites this paper
• Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial

  2011cites this paper
• Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola

  2011cites this paper
• Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

  2011cites this paper
• Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications

  2011cites this paper
• Selection of Known Plasmodium falciparum Resistance-Mediating Polymorphisms by Artemether-Lumefantrine and Amodiaquine- Sulfadoxine-Pyrimethamine but Not Dihydroartemisinin- Piperaquine in Burkina Faso

  2010cites this paper
• Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum

  2010cites this paper
• Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda

  2010cites this paper
• Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus.

  2010cites this paper
• Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance

  2010influential citation
• Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.

  2010influential citation
• Genetic polymorphisms in plasmodium falciparum associated with resistance to artemisinin combination therapy: complexity of infection during short-term culture and characterization of in vitro sensitivity in Kampala Uganda

  2010cites this paper
• Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda: a prospective cohort study

  2010cites this paper
• Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.

  2009cites this paper
• Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.

  2009cites this paper
• Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda

  2009cites this paper
• Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa

  2009influential citation
• Novel pfdhps Haplotypes among Imported Cases of Plasmodium falciparum Malaria in the United Kingdom

  2009cites this paper
• Mechanisms of resistance of P. falciparum to aminoquino-

  2009cites this paper
• PREVENTION AND TREATMENT PRACTICES AND IMPLICATIONS FOR MALARIA CONTROL IN MUKONO DISTRICT UGANDA

  2008cites this paper
• Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in Plasmodium falciparum

  2008cites this paper
• Folate Biosynthesis – Reappraisal of Old and Novel Targets in the Search for New Antimicrobials

  2008cites this paper
• Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture.

  2008cites this paper
• Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.

  2008cites this paper
• Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.

  2008cites this paper
• Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children

  2007cites this paper
• Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.

  2007cites this paper
• Toxoplasma as a Model System for Apicomplexan Drug Discovery

  2007cites this paper
• Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

  2007cites this paper
• Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.

  2007cites this paper
• Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda

  2007cites this paper
• "Plasmodium falciparum" drug resistance, molecular genotyping and generation of a malaria resistance genogram by DNA microarray-based technology

  2006cites this paper
• Plasmodium falciparum drug resistance, molecular genotyping and generation of a malaria resistance genogram by DNA microarray-based technology

  2006cites this paper
• Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.

  2006cites this paper
• Randomised Trial of Chloroquine/Sulphadoxine-Pyrimethamine in Gambian Children with Malaria: Impact against Multidrug-Resistant P. falciparum

  2006cites this paper
• Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.

  2006cites this paper
• Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum

  2006cites this paper
• Molecular epidemiology of malaria in Cameroon. XXII. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles.

  2006cites this paper
• Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.

  2006cites this paper
• Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal

  2005cites this paper
• Antimicrobial agents : bacterial / fungal Non typhoid salmonellosis : the Israeli experience and review of the literature 563

  2005cites this paper
• Artemisinin versus Nonartemisinin Combination Therapy for Uncomplicated Malaria: Randomized Clinical Trials from Four Sites in Uganda

  2005cites this paper
• Prevention and treatment practices and implications for malaria control in Mukono District Uganda

  year unknowncites this paper
• Prevention and treatment practices and implications for malaria control in Mukono District Uganda

  year unknowncites this paper
• Prevention and treatment practices and implications for malaria control in Mukono District Uganda

  year unknowncites this paper
• Prevention and treatment practices and implications for malaria control in Mukono District Uganda

  year unknowncites this paper
• Prevention and treatment practices and implications for malaria control in Mukono District Uganda

  year unknowncites this paper